Cytek Biosciences Inc. (CTKB)
undefined
undefined%
At close: undefined
6.21
0.32%
After-hours Dec 13, 2024, 04:00 PM EST

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
Year FY23 FY22 FY21 FY20 FY19
Revenue 193.01M 164.04M 127.95M 92.84M 57.88M
Cost of Revenue 83.59M 63.06M 48.81M 41.13M 29.21M
Gross Profit 109.43M 100.97M 79.14M 51.71M 28.67M
Operating Income -27.84M -1.83M 6.45M 13.66M 3.73M
Interest Income 6.41M 4.62M 49.00K 110.00K 711.00K
Pretax Income -15.71M 1.26M 5.95M 14.43M -16.29M
Net Income -12.15M 2.58M 4.42M 19.41M -16.83M
Selling & General & Admin 91.62M 67.92M 45.53M 24.36M 16.98M
Research & Development 44.15M 34.86M 24.44M 13.69M 8.93M
Other Expenses - 1.02M -1.53M 994.00K 252.00K
Operating Expenses 137.27M 102.78M 69.98M 38.05M 25.91M
Interest Expense 2.07M 2.57M 1.74M 333.00K 1K
Selling & Marketing Expenses 49.15M 33.23M 24.71M 14.99M 10.24M
Cost & Expenses 220.86M 165.84M 118.78M 79.18M 55.12M
Income Tax -3.56M -1.22M 1.50M -4.98M 533.00K
Shares Outstanding (Basic) 135.28M 134.51M 133.75M 132.99M 132.99M
Shares Outstanding (Diluted) 135.28M 138.56M 133.75M 132.99M 132.99M
EPS (Basic) -0.09 0.02 0.03 0.02 -0.13
EPS (Diluted) -0.09 0.02 0.03 0.02 -0.13
EBITDA -4.41M 9.54M 10.40M 15.37M -15.98M
Depreciation & Amortization 9.23M 5.70M 1.24M 603.00K 309.00K